• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE Back to Search Results
Model Number ESS305
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Emotional Changes (1831); Fatigue (1849); Pain (1994); Cramp(s) (2193); Heavier Menses (2666)
Event Type  Injury  
Event Description
This spontaneous case was reported by a lawyer and describes the occurrence of pelvic pain ('pelvic pain') in an adult female patient who had essure (batch no.D23516, d23515) inserted for female sterilization.The occurrence of additional non-serious events is detailed below.The patient's medical history included pancreatectomy in 2008, splenectomy in 2008, parathyroidectomy, cholecystectomy and morbid obesity.Concurrent conditions included multiple endocrine neoplasia type 1.On (b)(6) 2016, the patient had essure inserted.In 2017, the patient experienced genital haemorrhage ("general abnormal bleed"), dyspareunia ("dyspareunia (painful sexual intercourse)"), abdominal pain ("abdominal pain"), menorrhagia ("menorrhagia") and vaginal haemorrhage ("abnormal bleeding (vaginal)").On an unknown date, the patient experienced pelvic pain (seriousness criteria medically significant and intervention required), abdominal pain lower ("cramping"), psychological trauma ("psych injury"), fatigue ("fatigue") and dysmenorrhoea ("dysmenorrhea (cramping)").The patient was treated with surgery (supracervical hysterectomy (uterus only)).Essure was removed on (b)(6) 2020.At the time of the report, the pelvic pain, abdominal pain, menorrhagia and vaginal haemorrhage had resolved and the genital haemorrhage, dyspareunia, abdominal pain lower, psychological trauma, fatigue and dysmenorrhoea outcome was unknown.The reporter considered abdominal pain, abdominal pain lower, dysmenorrhoea, dyspareunia, fatigue, genital haemorrhage, menorrhagia, pelvic pain, psychological trauma and vaginal haemorrhage to be related to essure.The reporter commented: on right side of tube 6 coils and left side 5 coils were noted as per pfs discrepancy noted in date of insertion: (b)(6) 2016 discrepancy noted in essure confirmation test.Diagnostic results (normal ranges are provided in parenthesis if available): body mass index was 32.2 kg/sqm.Imaging procedure - on (b)(6) 2016: essure confirmation test(s) (unspecified) - bilateral occlusion.Concerning the injuries reported in this case, the following ones were described in patient¿s medical records : abdominal pain lot number: d23515 manufacturing date: 2014-10 expiration date: 2017-10.Lot number: d23516 manufacturing date: 2014-10 expiration date: 2017-10.Quality-safety evaluation of ptc: unable to confirm complaint.Most recent follow-up information incorporated above includes: on 4-feb-2020: pfs received events "abnormal bleeding (vaginal), dysmenorrhea (cramping)" were added.Outcome of event "abnormal bleeding, pelvic and abdominal pain" were updated as recovered.A technical investigation will be conducted, including a batch review, and a review of complaint records and other relevant data; should any new and reportable information become available from our investigation, this will be provided in a supplementary report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
Manufacturer (Section G)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM   13353
Manufacturer Contact
k shaw lamberson
100 bayer blvd, p.o. box 915
whippany, NJ 07981
MDR Report Key9726869
MDR Text Key190008078
Report Number2951250-2020-01545
Device Sequence Number1
Product Code HHS
UDI-Device Identifier10888853003051
UDI-Public(01)10888853003051
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Reporter Occupation Other
Type of Report Initial
Report Date 02/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/01/2017
Device Model NumberESS305
Device Lot NumberD23516, D23515
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/26/2019
Initial Date FDA Received02/19/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/01/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Weight88
-
-